This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Juergen Mueller, PhD
Commercial and Strategic Development Director Oligo-therapeutics at LGC Axolabs
Speaker

Profile

Juergen has more than >20 years in the Life Science industry while having held senior management positions in BD, Sales and Marketing, Licensing and Project Management from Fortune 500 companies, such as Sigma-Aldrich (US), up to service providers as Solvias (CH), and leading Oligo CMO’s as Nitto-Avecia (US/Jpn). Drug development experience as CSO for Syndeco (CH) while developing small molecule and peptide NCE’s from lead to clinical candidates. Author and inventor of >40 peer reviewed scientific articles and patents.

Agenda Sessions

  • LGC’s Development of a Novel, Modular, GalNAc Access, and Conjugation Strategies for Nucleic Acid Medicines

    On Demand - For Members
    View Session

At this event

Prev
Next
Gary Musso, PhD
President
Musso and Associates LLC

See Juergen at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub